{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:03:42Z","timestamp":1789689822235,"version":"4.0.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Systemic mastocytosis with an associated myeloid neoplasm (SM-AMN) represents a diagnostic challenge. The first section of the XVI European Bone Marrow Working Group Workshop, held in Barcelona, Spain, in 2023, focused on such cases. Three main lessons were learned from the workshop. First, both the SM and the AMN components can mask each other. Second, because of their overlapping clinical and laboratory findings, it is usually impossible to recognize advanced systemic mastocytosis within an SM-AMN. In other words, unless the International Consensus Classification \u201cC\u201d findings were clearly caused by the SM, for purposes of classification, the SM component was regarded as not advanced. The distinction between indolent and smoldering SM was impossible, but the presence of mast cell leukemia as the SM component is usually recognizable and should be reported. Finally, the presence of myeloid gene mutations (other than KIT) were strongly associated with SM-AMN. These variations include SRFS2-p95, biallelic (double) TET2 or a TET2 mutation combined with an SRSF2 variation to identify chronic myelomonocytic leukemia associated with SM. Additional diagnostic issues included disease progression in the SM or the AMN component, the distinction between SM-AMN and acute myeloid leukemia with partial mast cell differentiation (aka, myelomastocytic leukemia), and rare types of disease proliferations occurring in SM-AMN.<\/jats:p>","DOI":"10.1093\/ajcp\/aqaf042","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T07:31:42Z","timestamp":1744702302000},"page":"289-301","source":"Crossref","is-referenced-by-count":2,"title":["Systemic mastocytosis with an associated myeloid neoplasm: Report from the XVI European Bone Marrow Working Group Course and Workshop, Barcelona 2023"],"prefix":"10.1093","volume":"164","author":[{"given":"Roos J","family":"Leguit","sequence":"first","affiliation":[{"name":"Department of Pathology, University Medical Center Utrecht , Utrecht ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rozman","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de hematopatolog\u00eda, Departamento de patolog\u00eda, Hospital Cl\u00ednica Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Michael","family":"Kvasnicka","sequence":"additional","affiliation":[{"name":"University Clinic Wuppertal, University of Witten\/Herdecke , Wuppertal ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P","family":"Hasserjian","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital , Boston, MA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor","family":"Arenillas","sequence":"additional","affiliation":[{"name":"Laboratorio de Citolog\u00eda Hematol\u00f3gica, Departamento de Patolog\u00eda, Hospital del Mar , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estella","family":"Matutes","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de hematopatolog\u00eda, Departamento de patolog\u00eda, Hospital Cl\u00ednica Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fina","family":"Climent","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Medical Center Utrecht , Utrecht ,","place":["the Netherlands"]},{"name":"Departamento de Patolog\u00eda, Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1660-7013","authenticated-orcid":false,"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[{"name":"Department of Pathology, PL Foster School of Medicine, Texas Tech University Health Sciences Center El Paso , El Paso, TX ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"2025091004263711200_CIT0001","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1016\/j.jaip.2020.05.005","article-title":"Importance of adequate diagnostic workup for correct diagnosis of advanced systemic mastocytosis","volume":"8","author":"Schwaab","year":"2020","journal-title":"J Allergy Clin Immunol Pract."},{"key":"2025091004263711200_CIT0002","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaip.2018.09.024","article-title":"The Data Registry of the European Competence Network on Mastocytosis (ECNM): set up, projects, and perspectives","volume":"7","author":"Valent","year":"2019","journal-title":"J Allergy Clin Immunol Pract."},{"key":"2025091004263711200_CIT0003","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00428-022-03423-3","article-title":"The International Consensus Classification of mastocytosis and related entities","volume":"482","author":"Leguit","year":"2023","journal-title":"Virchows Arch."},{"key":"2025091004263711200_CIT0004","doi-asserted-by":"publisher","first-page":"292","DOI":"10.7150\/thno.51872","article-title":"Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis","volume":"11","author":"Kluin-Nelemans","year":"2021","journal-title":"Theranostics."},{"key":"2025091004263711200_CIT0005","doi-asserted-by":"publisher","first-page":"e85362","DOI":"10.1371\/journal.pone.0085362","article-title":"ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases","volume":"9","author":"Damaj","year":"2014","journal-title":"PLoS One."},{"key":"2025091004263711200_CIT0006","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1182\/blood.2019000932","article-title":"New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis","volume":"135","author":"Reiter","year":"2020","journal-title":"Blood."},{"key":"2025091004263711200_CIT0007","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1182\/asheducation-2018.1.127","article-title":"The new tool \u201cKIT\u201d in advanced systemic mastocytosis","volume":"2018","author":"Shomali","year":"2018","journal-title":"Hematol Am Soc Hematol Educ Program."},{"key":"2025091004263711200_CIT0008","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/j.1365-2362.2009.02184.x","article-title":"Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology","volume":"39","author":"Sperr","year":"2009","journal-title":"Eur J Clin Invest."},{"key":"2025091004263711200_CIT0009","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1002\/ajh.27478","article-title":"Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurin","volume":"99","author":"Heiblig","year":"2024","journal-title":"Am J Hematol."},{"key":"2025091004263711200_CIT0010","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/ajh.26966","article-title":"The International Consensus Classification of eosinophilic disorders and systemic mastocytosis","volume":"98","author":"Wang","year":"2023","journal-title":"Am J Hematol."},{"key":"2025091004263711200_CIT0011","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ajcp\/aqaa183","article-title":"Mastocytosis","volume":"155","author":"Tzankov","year":"2021","journal-title":"Am J Clin Pathol."},{"key":"2025091004263711200_CIT0012","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/leu.2011.293","article-title":"An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis","volume":"26","author":"Teodosio","year":"2012","journal-title":"Leukemia."},{"key":"2025091004263711200_CIT0013","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/ajh.25265","article-title":"Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases","volume":"93","author":"Shah","year":"2018","journal-title":"Am J Hematol."},{"key":"2025091004263711200_CIT0014","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/path.2677","article-title":"Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD)","volume":"220","author":"Sotlar","year":"2010","journal-title":"J Pathol."},{"key":"2025091004263711200_CIT0015","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood."},{"key":"2025091004263711200_CIT0016","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000504099","article-title":"The spectrum of aggressive mastocytosis: a workshop report and literature review","volume":"87","author":"Leguit","year":"2020","journal-title":"Pathobiology."},{"key":"2025091004263711200_CIT0017","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1182\/blood-2013-04-496448","article-title":"Comprehensive mutational profiling in advanced systemic mastocytosis","volume":"122","author":"Schwaab","year":"2013","journal-title":"Blood."},{"key":"2025091004263711200_CIT0018","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev-pathmechdis-031521-042618","article-title":"New insights into the pathogenesis of mastocytosis: emerging concepts in diagnosis and therapy","volume":"18","author":"Valent","year":"2023","journal-title":"Annu Rev Pathol."},{"key":"2025091004263711200_CIT0019","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s41379-019-0447-x","article-title":"Detection of the KITD816V mutation in myelodysplastic and\/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis","volume":"33","author":"Craig","year":"2020","journal-title":"Mod Pathol."},{"key":"2025091004263711200_CIT0020","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/ajh.24426","article-title":"Next-generation sequencing in systemic mastocytosis: Derivation of a mutation-augmented clinical prognostic model for survival","volume":"91","author":"Pardanani","year":"2016","journal-title":"Am J Hematol."},{"key":"2025091004263711200_CIT0021","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3324\/haematol.2013.095133","article-title":"SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes","volume":"99","author":"Hanssens","year":"2014","journal-title":"Haematologica."},{"key":"2025091004263711200_CIT0022","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/leu.2015.284","article-title":"Additional mutations in SRSF2, ASXL1 and\/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis","volume":"30","author":"Jawhar","year":"2016","journal-title":"Leukemia."},{"key":"2025091004263711200_CIT0023","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/leu.2015.4","article-title":"Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event","volume":"29","author":"Jawhar","year":"2015","journal-title":"Leukemia."},{"key":"2025091004263711200_CIT0024","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.leukres.2006.03.006","article-title":"Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone","volume":"31","author":"Pullarkat","year":"2007","journal-title":"Leuk Res."},{"key":"2025091004263711200_CIT0025","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/ajh.23380","article-title":"Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chromosomal abnormalities in SM and AHNMD components","volume":"88","author":"Wang","year":"2013","journal-title":"Am J Hematol."},{"key":"2025091004263711200_CIT0026","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1182\/blood.2019004229","article-title":"Molecular landscape and clonal architecture of adult myelodysplastic\/myeloproliferative neoplasms","volume":"136","author":"Palomo","year":"2020","journal-title":"Blood."},{"key":"2025091004263711200_CIT0027","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1038\/s41375-022-01733-8","article-title":"Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia","volume":"36","author":"Garcia-Gisbert","year":"2022","journal-title":"Leukemia."},{"key":"2025091004263711200_CIT0028","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1038\/leu.2016.126","article-title":"RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features","volume":"30","author":"Gaidzik","year":"2016","journal-title":"Leukemia."},{"key":"2025091004263711200_CIT0029","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1182\/blood.V130.Suppl_1.2916.2916","article-title":"Systemic mastocytosis with associated acute myeloid leukemia (SM-AML): a poor-risk multi-mutated disease that follows a distinct diagnostic algorithm and requires high-dose stem cell-targeting therapy","volume":"130(suppl 1)","author":"Jawhar","year":"2017","journal-title":"Blood."},{"key":"2025091004263711200_CIT0030","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/leu.2017.15","article-title":"Proposed diagnostic criteria and classification of basophilic leukemias and related disorders","volume":"31","author":"Valent","year":"2017","journal-title":"Leukemia."},{"key":"2025091004263711200_CIT0031","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jmoldx.2010.10.004","article-title":"Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay","volume":"13","author":"Kristensen","year":"2011","journal-title":"J Mol Diagn."},{"key":"2025091004263711200_CIT0032","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.jaip.2022.05.036","article-title":"Standards of pathology in the diagnosis of systemic mastocytosis: recommendations of the EU-US Cooperative Group","volume":"10","author":"Sotlar","year":"2022","journal-title":"J Allergy Clin Immunol Pract."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/164\/3\/289\/63995997\/aqaf042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/164\/3\/289\/63995997\/aqaf042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T08:26:42Z","timestamp":1757492802000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/164\/3\/289\/8229563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,8,9]]},"published-print":{"date-parts":[[2025,9,9]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqaf042","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,8,9]]}}}